TABLE 3

In vitro potency and duration of action of CHF5407 as compared with tiotropium, ipratropium, and glycopyrrolate in blocking muscarinic M3 receptor-mediated bronchoconstriction in human and guinea pig airways or M2 receptor-mediated inhibition of electrically induced twitch contractions in guinea pig left atrium

All data are mean ± S.E.M. of at least four observations.

CompoundGuinea Pig Trachea (Carbachol-Contracted)Guinea Pig Trachea (EFS-StimulatedHuman BronchusGuinea Pig Left Atrium
pIC50t½% Recovery (at 4.5 h)pIC50t½% Recovery (at 4 h)pIC50t½% Recovery (at 6 h)pIC50t½% Recovery (at 4.5 h)
hhhh
CHF54079.0 ± 0.04>411 ± 59.1 ± 0.25>409.6 ± 0.01>611 ± 98.2 ± 0.21.0 ± 0.173 ± 3
Tiotropium9.1 ± 0.001>410 ± 39.3 ± 0.09>409.5 ± 0.04>625 ± 28.7 ± 0.13.3a ± 0.258 ± 4
Ipratropium8.6 ± 0.020.5 ± 0.170 ± 79.2 ± 0.240.25 ± 0.175 ± 89.5 ± 0.043.0 ± 0.2110 ± 10NTNTNT
Glycopyrrolate9.0 ± 0.074.0 ± 0.550 ± 8NTNTNT10.4 ± 0.023.7 ± 0.2101 ± 10NTNTNT
  • pIC50 represents the log molar concentration of the test antagonist producing a 50% reversal of carbachol or electrical-induced effect. t1/2 (offset) is the time taken for response to carbachol or electrical field stimulation to return to 50% recovery after washout of the test antagonist. % Recovery indicates percentage response to carbachol or electrical field stimulation obtained 4 or 6 h after the washout of the test antagonist. Data for glycopyrrolate and part of data for ipratropium are from Villetti et al., 2006. NT, not tested.

  • a Significantly different from t1/2 of CHF5407; P < 0.05.